Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The . gov means it’s official VSports app下载. Federal government websites often end in . gov or . mil. Before sharing sensitive information, make sure you’re on a federal government site. .

Https

The site is secure V体育官网. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. .

. 2009 Nov 17;106(46):19467-72.
doi: 10.1073/pnas.0911436106. Epub 2009 Nov 9.

Prevention and treatment of cervical cancer in mice using estrogen receptor antagonists

Sang-Hyuk Chung  1 , Paul F Lambert
Affiliations

VSports app下载 - Prevention and treatment of cervical cancer in mice using estrogen receptor antagonists

Sang-Hyuk Chung et al. Proc Natl Acad Sci U S A. .

V体育2025版 - Abstract

The majority of human cervical cancers are associated with the high-risk human papillomavirus (HPV) types. In mouse models for HPV-associated cancers, estrogen is required for the development of cervical and vaginal cancers. The estrogen receptor alpha (ERalpha) also is required in mice for these cancers to arise. These data are consistent with the observation in women that long-term use of oral contraceptives or multiple pregnancies significantly increases the risk for cervical cancer in HPV-positive women. In the present study, we examined whether drugs that interfere with the function of ERalpha are effective in treating and/or preventing cervical cancer in mice. We provide evidence that a complete ER antagonist, ICI 182,780 (ICI), as well as a selective ER modulator, raloxifene, efficiently clear cancer and its precursor lesions in both the cervix and the vagina. Furthermore, ICI was capable of preventing the onset of cancers in mice bearing precursor lesions VSports手机版. These findings point to the potential value of ER antagonists in controlling gynecological disease in the lower reproductive tracts in women. .

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1.
Fig. 1.
Therapeutic treatment with ICI or raloxifene for 1 month results in regression of cervical disease. (A) Treatment regimens for the therapeutic approach are depicted. See Materials and Methods for details. ICI and Ral stand for ICI 182,780 (fulvestrant) and raloxifene, respectively. (B) Comparison of cervical cancer size in indicated treatment groups. Cancer size (largest cross-sectional area of each cancer) was determined as previously described (19). Mice that did not have cancers were assigned a value of 0. Gray bar represents median value for each group. P values from two-sided Wilcoxon rank sum test are shown. (C) Shown are high-magnification images of representative H&E-stained endocervical sections from indicated groups of mice. Arrows point to some dysplastic cells with dark, enlarged nuclei. Note that cervical dysplasias (CIN) are evident in mice not treated with ICI (i and ii) or treated with ICI for 1 week (iii) but are absent in mice treated with ICI for a longer period (iv and v). The black line delineates the basement membrane that separates epithelium from underlying stroma. (Scale bar, 50 μm.) (D) Shown are low-magnification images of representative H&E-stained endocervical sections from indicated groups of mice. Note that entire fields show cancer in mice not treated with ICI (i and ii). Also note that epithelium of ICI-treated mice (iii and iv) is much thinner than that of untreated mice (v). The arrowhead points to the small cancer remaining in mice treated with ICI for 2 weeks (iii). (Scale bar, 100 μm.) (E) Transition from columnar epithelium to squamous epithelium is present only once in normal cervix (i; normal squamous metaplasia). In ASM, however, it occurs multiple times, and thus patches of squamous epithelium are embedded within columnar epithelium (ii and iii). Note that ASM is absent in mice treated with ICI (iv) or raloxifene (v). Arrows point to transition from columnar epithelium to squamous epithelium. (Scale bar, 200 μm.)
Fig. 2.
Fig. 2.
Cancers remaining after therapeutic ICI treatment are associated with nonhypoplastic epithelium. (A) (Left) Low-magnification images of the two cancers [one cervical (Upper) and the other vaginal (Lower)] that persisted in 2 of 13 mice treated with ICI for 1 month. Black and gray arrowheads point to cancers and cancer-associated epithelia, respectively. (Scale bar, 100 μm.) (Right) High-magnification images of cervical (Upper) or vaginal (Lower) epithelium that was immediately juxtaposed to these two cancers. Note the nonhypoplastic (i.e., thick) epithelium akin to what is seen in female mice in normal estrus (see Fig. 1Dv). This is in stark contrast to the hypoplastic epithelia found elsewhere in the reproductive tracts of these same ICI-treated mice (Insets), as well as in the other ICI-treated, cancer-free mice (see Fig. 1Cv). White arrowheads point to dysplastic cells. Black lines delineate the basement membrane. (Scale bar, 50 μm.) (B) Cancers remaining in ICI-treated mice express ERα. Tissues were stained for ERα (red) and K14 (green), an epithelial cell marker. Arrowheads and arrows point to cancers and cancer-associated epithelia, respectively. (Scale bar, 50 μm.)
Fig. 3.
Fig. 3.
One-month ICI treatment prevents the onset of cervical cancer. (A) Treatment regimens for the preventive approach are depicted. See Materials and Methods for details. (B) Shown are high-magnification images of representative H&E-stained endocervical sections from indicated groups of mice. Unlike epithelia of mice in the E2(6m) or E2(3m) group, those in the E2(6m)/preventive ICI(1m) group are indistinguishable from normal epithelia of untreated mice in estrus. Black lines delineate the basement membrane. (Scale bar, 25 μm.)
Fig. 4.
Fig. 4.
A model for cervical carcinogenesis. See the text for details.
See this image and copyright information in PMC

References

    1. zur Hausen H. Papillomaviruses and cancer: From basic studies to clinical application. Nat Rev Cancer. 2002;2:342–350. - PubMed
    1. Roden R, Wu TC. How will HPV vaccines affect cervical cancer? Nat Rev Cancer. 2006;6:753–763. - "VSports app下载" PMC - PubMed
    1. Cline JM. Neoplasms of the reproductive tract: The role of hormone exposure. ILAR J. 2004;45:179–188. - PubMed
    1. Moreno V, et al. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: The IARC multicentric case-control study. Lancet. 2002;359:1085–1092. - PubMed
    1. Munoz N, et al. Role of parity and human papillomavirus in cervical cancer: The IARC multicentric case-control study. Lancet. 2002;359:1093–1101. - PubMed

Publication types

MeSH terms (V体育ios版)